Bank of Montreal’s Vera Therapeutics VERA Stock Holding History

Bank of Montreal’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-96,849	Closed	-$1.41K	–	4429
2022 Q2	$1.41K	Buy	+96,849	New	+$1.69M	﹤0.01%	2093

Other funds holding VERA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Bank of Montreal's VERA Position: Q3 2022 in Review

Bank of Montreal sold out of Vera Therapeutics (VERA) in Q3 2022, closing a stake of 96,849 shares — an estimated $1.41K sold.

Bank of Montreal first reported a position in VERA in Q2 2022 and held it in 1 quarter. The position peaked at $1.41K in Q2 2022. 55 funds tracked by Wall St. Rank hold VERA as of Q3 2022.

Bank of Montreal reported no remaining Vera Therapeutics position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 96,849 Vera Therapeutics shares in Q3 2022, an estimated $1.41K.
Bank of Montreal first reported a position in Vera Therapeutics in Q2 2022 and held it in 1 quarter.
Bank of Montreal's Vera Therapeutics position peaked at $1.41K in Q2 2022.
55 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.